Researchers found that a prescription for healthy food can improve health outcomes for beneficiaries in Medicare and Medicaid.
Eating a healthy diet can have enough of a health impact that it is cost effective to offset the cost of purchasing such food with health insurance coverage, according to new research published in PLoS Medicine.
Researchers found that a prescription for healthy food can improve health outcomes for beneficiaries in Medicare and Medicaid. The authors estimated the economic health benefits in 2 scenarios: if 30% of the cost of fruit and vegetables in supermarkets were covered (F&V incentive) and if 30% of the cost of fruits, vegetables, whole grains, nuts/seeds, seafood, and plant-based oils (healthy food incentive) were covered through Medicare and Medicaid.
The authors used a microsimulation model to estimate the number of cardiovascular disease and diabetes cases that would be prevented, quality-adjusted life years (QALYs), health-related costs, and incremental cost-effectiveness ratios for both scenarios. They estimated that under the F&V incentive, 1.93 million cardiovascular disease events would be prevented, 4.64 million QALYs gained, and $39.7 billion in formal healthcare costs saved. They estimated the saved costs: under the healthy food incentive, 3.28 million cardiovascular events and 0.12 million diabetes cases would be prevented, 8.40 million QALYs gained, and $100.2 billion in formal healthcare costs saved.
"We found that encouraging people to eat healthy foods in Medicare and Medicaid—healthy food prescriptions—could be as or more cost effective as other common interventions, such as preventative drug treatments for hypertension or high cholesterol," co-first author Yujin Lee, PhD, postdoctoral fellow at the Friedman School of Nutrition Science and Policy at Tufts University, said in a statement.
Given the savings of $39.7 billion for the F&V incentive and $100.2 million for the healthy food incentive and the fact that food subsidy and other policy costs were $122.6 billion and $210.4 billion, respectively, the authors considered the programs highly cost effective. Typically, medical interventions are considered cost effective if they cost less than $150,000 per QALY gained and are considered highly cost effective when less than $50,000 per QALY gained. The researchers calculated that the F&V incentive had incremental costs of $18,184 per QALY and the healthy food incentive had incremental costs of $13,194 per QALY.
Since Medicare has a larger population size, they estimated that the absolute health benefits were larger in the Medicare program compared with the Medicaid or dual-eligible populations. Both scenarios were cost effective at 5 and 10 years, and they were modestly more cost effective for Medicare and dual-eligibles. According to the authors, this is because Medicare and dual-eligible beneficiaries are older than Medicaid adult enrollees, “resulting in larger absolute reductions in cardiometabolic events and subsequent healthcare savings over a shorter timeframe.”
They noted that the findings of the study support pilot and demonstration programs testing the feasibility of incentivizing healthy foods through Medicare and Medicaid.
"These new findings support the concept of Food is Medicine: That innovative programs to encourage and reimburse healthy eating can and should be integrated into the healthcare system," said co-first author Dariush Mozaffarian, MD, DrPH, dean of the Friedman School of Nutrition Science and Policy at Tufts.
Reference
Lee Y, Mozaffarian D, Sy S, et al. Cost-effectiveness of financial incentives for improving diet and health through Medicare and Medicaid: A microsimulation study [published online March 19, 2019]. PLOS Medicine. doi: 10.1371/journal.pmed.1002761.
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More
Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes
November 19th 2024Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Contributor: The Diabetes Vendor Resource Guide—A Useful Directory for Employers
November 13th 2024Employees living with diabetes often face unique challenges, such as managing blood sugar levels, balancing medication, and preventing complications, all while maintaining their professional responsibilities. This condition can lead to increased absenteeism, reduced productivity, and rising health care costs.
Read More